Gabriel Bsteh

3.0k total citations
138 papers, 1.6k citations indexed

About

Gabriel Bsteh is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Gabriel Bsteh has authored 138 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Pathology and Forensic Medicine, 68 papers in Neurology and 32 papers in Oncology. Recurrent topics in Gabriel Bsteh's work include Multiple Sclerosis Research Studies (94 papers), Peripheral Neuropathies and Disorders (40 papers) and Polyomavirus and related diseases (29 papers). Gabriel Bsteh is often cited by papers focused on Multiple Sclerosis Research Studies (94 papers), Peripheral Neuropathies and Disorders (40 papers) and Polyomavirus and related diseases (29 papers). Gabriel Bsteh collaborates with scholars based in Austria, Germany and Switzerland. Gabriel Bsteh's co-authors include Thomas Berger, Harald Hegen, Franziska Di Pauli, Florian Deisenhammer, Michael Auer, Paulus Rommer, Klaus Berek, Sebastian Wurth, Fritz Leutmezer and Nik Krajnc and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Gabriel Bsteh

125 papers receiving 1.6k citations

Peers

Countries citing papers authored by Gabriel Bsteh

Since Specialization

Citations

This map shows the geographic impact of Gabriel Bsteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Bsteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Bsteh more than expected).

Fields of papers citing papers by Gabriel Bsteh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Bsteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Bsteh. The network helps show where Gabriel Bsteh may publish in the future.

Co-authorship network of co-authors of Gabriel Bsteh

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Bsteh. A scholar is included among the top collaborators of Gabriel Bsteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Bsteh. Gabriel Bsteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of renal function impairment on kappa free light chain index 2025 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), (unknown), Klaus Berek, Michael Auer, (unknown), Franziska Di Pauli, Nik Krajnc, Markus Ponleitner, Anne Zinganell, Tobias Zrzavy, Florian Deisenhammer, Janette Walde, Gabriel Bsteh, Harald Hegen	2
2	Kappa Free Light Chain Index and Oligoclonal Bands in Varicella Zoster Virus Infection and Neuroborreliosis: A Matter of Timing? 2025 ·European Journal of Neurology ·Klaus Berek, (unknown), Michael Auer, Gabriel Bsteh, Anne Zinganell, Florian Deisenhammer, Franziska Di Pauli, Harald Hegen	1
3	Short‐Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature Review 2025 ·European Journal of Neurology ·Anne Zinganell, Harald Hegen, Janette Walde, (unknown), Klaus Berek, Michael Auer, (unknown), Gabriel Bsteh, Alexander Kroiss, Andrea Griesmacher, (unknown), Alexander Tschoner, Thomas Berger, Florian Deisenhammer, Franziska Di Pauli	0
4	Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosis 2025 ·Multiple Sclerosis Journal ·Klaus Berek, (unknown), Gabriel Bsteh, Michael Auer, (unknown), Thomas Berger, Franziska Di Pauli, Astrid Grams, (unknown), (unknown), Dejan Milosavljevic, Anne Zinganell, (unknown), (unknown), Harald Hegen	1
5	Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis 2025 ·Neurology ·Gabriel Bsteh, Harald Hegen, Nik Krajnc, (unknown), Lukas Haider, Barbara Kornek, Fritz Leutmezer, Stefan Macher, (unknown), Markus Ponleitner, Paulus Rommer, (unknown), Karin Zebenholzer, Gudrun Zulehner, Tobias Zrzavy, Franziska Di Pauli, Berthold Pemp, Thomas Berger	0
6	Magnetic Resonance Imaging Signs of Idiopathic Intracranial Hypertension 2024 ·JAMA Network Open ·Dagmar Beier, (unknown), Gabriel Bsteh, Stefan Macher, Wolfgang Marik, Berthold Pemp, Hsiangkuo Yuan, (unknown), (unknown), (unknown), Snorre Malm Hagen, Christoph P. Beier, Simon Kristensen, Rigmor Jensen	5
7	An interdisciplinary integrated specialized one‐stop outpatient clinic for idiopathic intracranial hypertension—a comprehensive assessment of clinical outcome 2024 ·European Journal of Neurology ·Gabriel Bsteh, Stefan Macher, Nik Krajnc, Wolfgang Marik, (unknown), Nina Müller, (unknown), Jürgen Harreiter, Klaus Novak, Christian Wöber, Berthold Pemp	3
8	Investigation of serum neurofilament light chain as a biomarker in Fabry disease 2024 ·Scientific Reports ·Markus Ponleitner, (unknown), Gabriel Bsteh, Jakob Rath, Patrick Altmann, Thomas Berger, Senta Graf, Gere Sunder‐Plassmann, Paulus Rommer	1
9	Treating to target in multiple sclerosis: Do we know how to measure whether we hit it? 2024 ·European Journal of Neurology ·Gabriel Bsteh, Nik Krajnc, Patrick Altmann, Barry Hendin, (unknown), (unknown), Fred Lublin, Jiwon Oh, (unknown), Annemie Ribbens, (unknown), Dirk Smeets, Éric Thouvenot, (unknown), Thomas Berger	2
10	Disability progression is a question of definition—A methodological reappraisal by example of primary progressive multiple sclerosis 2024 ·Multiple Sclerosis and Related Disorders ·Gabriel Bsteh, (unknown), Nik Krajnc, (unknown), Anke Salmen, (unknown), Fritz Leutmezer, Paulus Rommer, Franziska Di Pauli, (unknown), Thomas Berger, Harald Hegen, Robert Hoepner	1
11	The Vienna idiopathic intracranial hypertension database—An Austrian registry 2023 ·Wiener klinische Wochenschrift ·(unknown), Christoph Mitsch, Stefan Macher, Nik Krajnc, Wolfgang Marik, Klaus Novak, Christian Wöber, Berthold Pemp, Gabriel Bsteh	10
12	The three pillars in treating antibody-mediated encephalitis 2023 ·Wiener klinische Wochenschrift ·Susanne Macher, Gabriel Bsteh, Ekaterina Pataraia, Thomas Berger, Romana Höftberger, Paulus Rommer	1
13	Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 infection: A systematic diagnostic approach 2023 ·European Journal of Neurology ·Birgit Ludwig, (unknown), Nik Krajnc, (unknown), Stefan Macher, Gabriel Bsteh, Gudrun Zulehner, Majda M. Thurnher, Thomas Berger, Stefan Seidel, Ulrike Willinger, Paulus Rommer	5
14	Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes 2023 ·Headache The Journal of Head and Face Pain ·Gabriel Bsteh, Stefan Macher, Nik Krajnc, (unknown), Wolfgang Marik, Christoph Mitsch, Klaus Novak, Berthold Pemp, Christian Wöber	10
15	Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis 2022 ·Neurology ·Gabriel Bsteh, Nik Krajnc, (unknown), Patrick Altmann, Barbara Kornek, Fritz Leutmezer, Stefan Macher, Christoph Mitsch, (unknown), Paulus Rommer, Gudrun Zulehner, Berthold Pemp, Thomas Berger, (unknown)	3
16	Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study 2022 ·European Journal of Neurology ·Gabriel Bsteh, (unknown), (unknown), (unknown), (unknown), Nik Krajnc, Franziska Di Pauli, Harald Hegen, (unknown), Fritz Leutmezer, Peter Wipfler, Gudrun Zulehner, Michael Guger, Christian Enzinger, Thomas Berger, (unknown)	20
17	Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis—a safety analysis and validation of the EANO-ESMO classification 2022 ·Strahlentherapie und Onkologie ·Sarah Iglseder, Martha Nowosielski, Gabriel Bsteh, Armin Muigg, (unknown), (unknown), Astrid Grams, Günther Stockhammer, Meinhard Nevinny‐Stickel	8
18	Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study 2022 ·European Journal of Neurology ·Gabriel Bsteh, Harald Hegen, (unknown), Nik Krajnc, Fritz Leutmezer, Franziska Di Pauli, Barbara Kornek, Paulus Rommer, Gudrun Zulehner, (unknown), (unknown), (unknown), (unknown), Michael Winklehner, Florian Deisenhammer, Michael Guger, Romana Höftberger, Thomas Berger	15
19	Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study 2021 ·Multiple Sclerosis Journal ·Gabriel Bsteh, (unknown), (unknown), Harald Hegen, (unknown), Fritz Leutmezer, Franziska Di Pauli, (unknown), (unknown), Gudrun Zulehner, Paulus Rommer, Peter Wipfler, Michael Guger, Romana Höftberger, Christian Enzinger, Thomas Berger	22
20	The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study 2021 ·JMIR Research Protocols ·Patrick Altmann, (unknown), Fritz Leutmezer, Markus Ponleitner, (unknown), Tobias Zrzavy, Gudrun Zulehner, Barbara Kornek, Rupert Lanzenberger, Klaus Berek, Paulus Rommer, Thomas Berger, Gabriel Bsteh	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact